Therapeutics: Multiple endocrine neoplasia I (MEN1; menin); myeloid-lymphoid or mixed-lineage leukemia (MLL; HRX)

Studies in cells, mice and patient samples suggest inhibiting the menin-MLL interaction could help treat acute leukemias driven by MLL fusion oncogenes. Chemical synthesis and testing in cellular assa...